Curis Inc (CRIS) Stock Price, Quote & News

Company Profile

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed or refractory, or R/R, AML and high-risk myelodysplastic syndromes. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 503 6500

Website: www.curis.com

Address:

Building C, Suite 500 128 Spring Street, Lexington, United States

PhantomSigma Aug. 23 at 10:16 AM

$CRIS Curis Inc is a clinical stage oncology company with development timeline risks

0 · Reply

BallWasher69 Aug. 22 at 8:26 PM

$CRIS https://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=319399947&type=HTML&symbol=CRIS&cdn=0db6007f08fae53250cbcebc27231116&companyName=Curis+Inc.&formType=8-K&dateFiled=2025-08-22

1 · Reply

Topzero Aug. 21 at 4:11 PM

$CRIS Don’t believe the garbage believe me go toDon’t believe the garbage believe me go to $.90

1 · Reply

Topzero Aug. 21 at 3:34 PM

$CRIS please, everyone don’t buy sale and out because the company liar and sell the share fucking the company

1 · Reply

Yodalay Aug. 21 at 3:13 PM

$CRIS Likely to see an extension here?

0 · Reply

UCD_12dd Aug. 21 at 1:20 PM

$CRIS up 3% pre market which means it will end red again today

0 · Reply

duck_man Aug. 21 at 1:06 AM

$CRIS so today is the 20th and i dont see any filings about an appeal? Are we going to OTC?

1 · Reply

LodiDodiWeLikesToParty Aug. 20 at 9:04 PM

$CRIS what do you mean, hopefully keep our shares?

1 · Reply

MaiXin Aug. 20 at 9:01 PM

$CRIS Stay focused...see the essence...share prices aren't important...look at the market capitalization based on the potential...sure, the price performance is disappointing, but this stock can eclipse everything we've seen in biotech in recent years. In the end, the duck poops...that's the way forward. We'll probably see a delisting, but we'll keep our shares anyway...hopefully...😎

0 · Reply

Topzero Aug. 20 at 2:07 PM

$CRIS garbage all liar

0 · Reply

Curis, Inc. (CRIS) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 8:00 AM EDT - 20 days ago

Curis Provides Second Quarter 2025 Business Update

Jul 29, 2025, 8:30 AM EDT - 27 days ago

Curis to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2025

Jul 2, 2025, 8:32 AM EDT - 7 weeks ago

Curis Announces $7.0 Million Registered Direct and Concurrent Private Placement

May 6, 2025, 6:16 PM EDT - 3 months ago

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

May 6, 2025, 2:40 PM EDT - 3 months ago

Curis, Inc. (CRIS) Q1 2025 Earnings Call Transcript

May 6, 2025, 8:00 AM EDT - 3 months ago

Curis Provides First Quarter 2025 Business Update

Apr 29, 2025, 8:00 AM EDT - 4 months ago

Curis to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2025

Apr 2, 2025, 4:05 PM EDT - 5 months ago

Curis to Present at Upcoming Healthcare Conference in April

Mar 31, 2025, 9:59 AM EDT - 5 months ago

Curis, Inc. (CRIS) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 8:00 AM EDT - 5 months ago

Curis Provides Fourth Quarter 2024 Business Update

Mar 28, 2025, 4:07 PM EDT - 5 months ago

Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025

Dec 10, 2024, 8:00 AM EST - 9 months ago

Curis Announces Additional Data from TakeAim Leukemia Study

Nov 14, 2024, 11:02 AM EST - 10 months ago

Curis, Inc. (CRIS) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 8:00 AM EST - 10 months ago

Curis Provides Third Quarter 2024 Business Update

Nov 7, 2024, 8:00 AM EST - 10 months ago

Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024

Oct 29, 2024, 6:04 AM EDT - 10 months ago

Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement

Sep 23, 2024, 8:30 AM EDT - 1 year ago

Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer

Sep 17, 2024, 7:30 AM EDT - 1 year ago

Curis to Participate at the Upcoming 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Curis to Present at Upcoming Healthcare Conferences in September

Aug 1, 2024, 3:44 PM EDT - 1 year ago

Curis, Inc. (CRIS) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 8:00 AM EDT - 1 year ago

Curis Provides Second Quarter 2024 Financial and Operating Update

Jul 25, 2024, 8:00 AM EDT - 1 year ago

Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024

Jul 10, 2024, 7:30 AM EDT - 1 year ago

Curis to Present at Upcoming Healthcare Conference in July

May 10, 2024, 8:00 AM EDT - 1 year ago

Curis to Present Updated Data from the TakeAim Leukemia Study

May 7, 2024, 8:08 PM EDT - 1 year ago

Curis, Inc. (CRIS) Q1 2024 Earnings Call Transcript

May 7, 2024, 8:00 AM EDT - 1 year ago

Curis Provides First Quarter 2024 Business Update

Apr 30, 2024, 8:00 AM EDT - 1 year ago

Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024

Apr 4, 2024, 7:30 AM EDT - 1 year ago

Curis to Present at Upcoming Healthcare Conferences in April

Feb 8, 2024, 2:04 PM EST - 1 year ago

Curis, Inc. (CRIS) Q4 2023 Earnings Call Transcript

Feb 8, 2024, 8:00 AM EST - 1 year ago

Curis Provides Fourth Quarter 2023 Business Update

Feb 1, 2024, 8:00 AM EST - 1 year ago

Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024

Dec 12, 2023, 8:00 AM EST - 1 year ago

Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study

Dec 11, 2023, 8:00 AM EST - 1 year ago

Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference

Dec 6, 2023, 8:00 AM EST - 1 year ago

Curis Announces Three Presentations at ASH

Dec 5, 2023, 8:00 AM EST - 1 year ago

Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma

Nov 17, 2023, 9:04 AM EST - 1 year ago

Curis's stock rises as analysts see ‘the next Pharmacyclics'

Nov 2, 2023, 2:32 PM EDT - 1 year ago

Curis, Inc. (CRIS) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 8:00 AM EDT - 1 year ago

Curis Provides Third Quarter 2023 Business Update

Oct 26, 2023, 8:30 AM EDT - 1 year ago

Curis to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023

Sep 12, 2023, 8:00 AM EDT - 2 years ago

Curis Announces Date for the 2nd Symposium on IRAK4 in Cancer

Aug 3, 2023, 9:35 PM EDT - 2 years ago

Curis, Inc. (CRIS) Q2 2023 Earnings Call Transcript

Aug 3, 2023, 4:01 PM EDT - 2 years ago

Curis Provides Second Quarter 2023 Business Update

Jul 27, 2023, 6:25 PM EDT - 2 years ago

Curis to Release Second Quarter 2023 Financial Results and Hold Conference Call on August 3, 2023

Jul 6, 2023, 8:01 AM EDT - 2 years ago

FDA Removes Partial Clinical Hold on TakeAim Leukemia Study RP2D Established at 300 mg BID

Jul 6, 2023, 8:00 AM EDT - 2 years ago

Curis Announces $15.1 Million Registered Direct Offering

May 4, 2023, 9:59 PM EDT - 2 years ago

Curis, Inc. (CRIS) Q1 2023 Earnings Call Transcript

May 4, 2023, 4:01 PM EDT - 2 years ago

Curis Provides First Quarter 2023 Business Update

Apr 27, 2023, 4:01 PM EDT - 2 years ago

Curis to Release First Quarter 2023 Financial Results and Hold Conference Call on May 4, 2023

PhantomSigma Aug. 23 at 10:16 AM

$CRIS Curis Inc is a clinical stage oncology company with development timeline risks

0 · Reply

BallWasher69 Aug. 22 at 8:26 PM

1 · Reply

Topzero Aug. 21 at 4:11 PM

$CRIS Don’t believe the garbage believe me go toDon’t believe the garbage believe me go to $.90

1 · Reply

Topzero Aug. 21 at 3:34 PM

$CRIS please, everyone don’t buy sale and out because the company liar and sell the share fucking the company

1 · Reply

Yodalay Aug. 21 at 3:13 PM

$CRIS Likely to see an extension here?

0 · Reply

UCD_12dd Aug. 21 at 1:20 PM

$CRIS up 3% pre market which means it will end red again today

0 · Reply

duck_man Aug. 21 at 1:06 AM

$CRIS so today is the 20th and i dont see any filings about an appeal? Are we going to OTC?

1 · Reply

LodiDodiWeLikesToParty Aug. 20 at 9:04 PM

$CRIS what do you mean, hopefully keep our shares?

1 · Reply

MaiXin Aug. 20 at 9:01 PM

0 · Reply

Topzero Aug. 20 at 2:07 PM

$CRIS garbage all liar

0 · Reply

LodiDodiWeLikesToParty Aug. 19 at 10:48 PM

$CRIS there is nothing scheduled as far as events, press releases, etc. Tomorrow must be judgement day. I wouldn't hire this CEO to manage anything. I don't think he can even manage himself.

0 · Reply

Yodalay Aug. 19 at 4:48 PM

$CRIS 2 weeks to go for the MVLS Requirement ($35 million mark for at least 10 consecutive business). Will they be granted an extension?

1 · Reply

LodiDodiWeLikesToParty Aug. 19 at 11:02 AM

$CRIS most of the charts don't even show the last 20 to 1 reverse split. These people are crooks.

3 · Reply

white__valkyrie Aug. 18 at 8:18 AM

$CRIS in the last fibe years what? what this company did? anything? What a waste of time for you guys

0 · Reply

terrapin22 Aug. 15 at 6:52 PM

$CRIS get em

0 · Reply

Topzero Aug. 14 at 4:59 PM

$CRIS We would like to open a discussion regarding the scheduled delisting of the company from the stock exchange on August 20, 2025. Are there any updates or requests for an extension to delay this process? It seems surprising that a company might abandon its shares, face delisting, and transition to trading on the OTC market. Is this a reasonable course of action for the company? We value your insights and would appreciate your thoughts on this matter.

1 · Reply

BallWasher69 Aug. 13 at 8:31 PM

$CRIS new 13G just filed: On August 13, 2025, M28 Capital Management LP and Marc Elia filed an amendment to acknowledge holding a 5.9% beneficial stake in Curis, all shared voting/dispositive power, including warrant-based shares, and maintain a passive investment posture under SEC rules. Aggregate Beneficial Ownership: 620,167 shares, which represents 5.9% of Curis’ outstanding common stock (based on a total of 10,561,358 shares as of May 2, 2025, reported in the company’s 10‑Q for Q1 2025)

0 · Reply

Love_To_Learn Aug. 12 at 7:10 PM

$CRIS $ADN HI

0 · Reply

Love_To_Learn Aug. 12 at 6:47 PM

$CRIS accessing portal 3.24 3's pt trace pattern 2.32 / channels 2.39 access to 11.54 pt sub cross other stock

0 · Reply

BallWasher69 Aug. 11 at 10:32 AM

$CRIS form S-1 filed this AM. ChatGPT summary below

1 · Reply

CmonManGiveMeABreak Aug. 10 at 1:21 AM

$CRIS wen delist pos

0 · Reply

MaiXin Aug. 8 at 4:49 AM

$CRIS New study: CA-4948 in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer https://clinicaltrials.gov/study/NCT07107750?cond=Ca4948&rank=7

1 · Reply

Market Cap	21.31M
Revenue (ttm)	10.91M
Net Income (ttm)	-43.39M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-397.71%
Debt to Equity Ratio	0.00

Volume	196,900
Avg Vol	116,600
Day's Range	N/A - N/A
Shares Out	12.50M
Stochastic %K	57%
Beta	3.66
Analysts	Strong Sell
Price Target	$14.50